VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Gandara Spotlights the Giants of Cancer Care

David R. Gandara, MD
Published: Friday, Jul 26, 2013

David R. Gandara, MD, Professor of Medicine, Division of Hematology and Oncology, Director, Thoracic Oncology Program, Associate Director, Clinical Research, UC Davis Cancer Center, discusses the 2013 recipient of the Giants of Cancer Care award in the field of thoracic oncology: Thomas J. Lynch, Jr., MD.

Lynch is well known across the United States as a leader in the field of thoracic oncology, Gandara notes. He is best known for leading the team that pioneered molecular testing for EGFR mutations in lung cancer. Lynch currently serves as the director of the Yale Cancer Center, where he is building an extraordinary lung cancer research team, Gandara adds.

The 2013 Giants of Cancer Care was conducted at the Hyatt Regency in Huntington Beach, California.

For more information on the Giants of Cancer Care, visit giants.onclive.com

David R. Gandara, MD, Professor of Medicine, Division of Hematology and Oncology, Director, Thoracic Oncology Program, Associate Director, Clinical Research, UC Davis Cancer Center, discusses the 2013 recipient of the Giants of Cancer Care award in the field of thoracic oncology: Thomas J. Lynch, Jr., MD.

Lynch is well known across the United States as a leader in the field of thoracic oncology, Gandara notes. He is best known for leading the team that pioneered molecular testing for EGFR mutations in lung cancer. Lynch currently serves as the director of the Yale Cancer Center, where he is building an extraordinary lung cancer research team, Gandara adds.

The 2013 Giants of Cancer Care was conducted at the Hyatt Regency in Huntington Beach, California.

For more information on the Giants of Cancer Care, visit giants.onclive.com




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x